In the summer of 2020, Texas Tech University's Office of Research Commercialization filed a patent application and applied for the COVID-19 Prioritized Examination Pilot Program with the U.S. Patent and Trade Office.
Mar 28, 2022
0
6
Tele-mentoring for primary care providers was associated with a decrease in hospitalizations for Medicaid patients with diabetes.
Mar 24, 2022
0
2
Starting on Jan. 25, 2023, many of the 2,500 institutions and 300,000 researchers that the U.S. National Institutes of Health supports will need to provide a formal, detailed plan for publicly sharing the data generated by ...
Mar 24, 2022
0
8
The number of adolescents who have attempted to quit e-cigarettes and failed has grown with the rapid increase of teen e-cigarette use in the past five years, according to a study by University of Michigan researchers.
Mar 22, 2022
0
50
Preclinical studies, the kind that scientists perform before testing in humans, don't get as much attention as their clinical counterparts. But they are the vital first steps to eventual treatments and cures. It's important ...
Mar 21, 2022
0
2
Calculating a person's risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, reports a new study led by a UCL researcher.
Mar 8, 2022
0
8
While the word "mutation" may conjure up alarming notions, a mutation in brain immune cells serves a positive role in protecting people against Alzheimer's disease. Now University of California, Irvine biologists have discovered ...
Feb 14, 2022
0
105
The head of the World Health Organization said Friday the acute phase of the pandemic could end this year, if around 70 percent of the world gets vaccinated.
Feb 11, 2022
0
32
The stretches of DNA that differ from person to person, called variants, are a major part of what makes us unique, but they can also put us at greater risk of disease. Although we can currently spell out between 80% and 90% ...
Feb 7, 2022
0
18
The UN-backed global Medicines Patent Pool on Thursday signed a 39-million-euro ($45 million) grant with South African biotech firm Afrigen to fund work on new mRNA COVID jabs.
Feb 3, 2022
0
3
